Home › Funds › CONTINENTAL ADVISORS LLC › GILD

CONTINENTAL ADVISORS LLC position in GILD

GILEAD SCIENCES INC · Health Care

CONTINENTAL ADVISORS LLC reported holding 28,367 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$4.2M, representing 2.30% of its reported portfolio and ranking #16 among its reported holdings. CONTINENTAL ADVISORS LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)28.37K sh
Reported value held$4.23M
Portfolio Weight2.30%
First reportedQ3 2023
Last changeHold
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How CONTINENTAL ADVISORS LLC's GILD position evolved

CONTINENTAL ADVISORS LLC first disclosed a stake in GILD in Q3 2023 at 81,903 shares (US$6.1M). Across 13 filings, CONTINENTAL ADVISORS LLC increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 28,367 shares valued at US$4.2M. Notable position changes include a 71% trim in Q1 2024 (shares fell 6% over the following quarter), a 131% increase in Q2 2024 (shares rose 22% over the following quarter), a 125% increase in Q4 2024 (shares rose 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 81.90K $6.14M New
Q4 2023 74.90K $6.07M Reduce
Q1 2024 22.00K $1.61M Reduce
Q2 2024 50.80K $3.49M Add
Q3 2024 25.00K $2.10M Reduce
Q4 2024 56.37K $5.21M Add
Q1 2025 44.87K $5.03M Reduce
Q2 2025 35.87K $3.98M Reduce
Q3 2025 34.37K $3.81M Reduce
Q4 2025 32.87K $4.03M Reduce
Q1 2026 28.37K $3.95M Reduce
Q2 2026 28.37K $3.58M Hold
Q3 2026 28.37K $4.23M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has CONTINENTAL ADVISORS LLC held GILD?

CONTINENTAL ADVISORS LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CONTINENTAL ADVISORS LLC's current position in GILD?

As of Q3 2026, CONTINENTAL ADVISORS LLC holds 28.37K shares of GILD (GILEAD SCIENCES INC), valued at $4.23M, representing 2.30% of its reported portfolio and ranking #16.

Has CONTINENTAL ADVISORS LLC been buying or selling GILD?

In the latest 13F filing (Q3 2026), CONTINENTAL ADVISORS LLC held unchanged its position in GILD.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.